Lacetti, Andrew et al. Phase 1/2 Trial of Oral EPI-7386 in Combination with Enzalutamide (Enz) Compared with Enz Alone in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC): Preliminary Results from the Phase 1 (P1) Dose-optimization Component of the Study. 2023 American Society of Clinical Oncology Genitourinary (ASCO GU) Symposium.

ASCO GU 2023 Poster Presentation